Skip to main content

General Catalyst Group Management, LLC

13F filer · CIK 0001637946
Reported Aug 17, 2026
13F portfolio value$189MU.S. long equity reported on 13F
Positions14Not reported new · 2 closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight99.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 17, 202614 positions
AVBPArriVent BioPharma, Inc.$51.9M27.55%3.09%Not reportedQ1 2024
PBLSParabilis Medicines, Inc.$43.8M23.24%1.31%NewQ2 2026
CARTMaplebear Inc.$33.7M17.85%0.31%Not reportedQ3 2023
MAZEMaze Therapeutics, Inc.$30.9M16.40%1.87%Not reportedQ1 2025
ODTXOdyssey Therapeutics, Inc.$15.2M8.04%1.69%NewQ2 2026
EIKNEikon Therapeutics, Inc.$3.98M2.11%0.56%Not reportedQ1 2026
GUTSFractyl Health, Inc.$3.88M2.06%3.08%0.0%Q2 2025
LIFEEthos Technologies Inc.$1.35M0.71%0.45%Not reportedQ1 2026
CPNGCoupang, Inc.$950K0.50%Not reported+49.1%Q1 2026
AMZNAmazon Com Inc$925K0.49%0.00%+50.4%Q1 2026
METAMeta Platforms, Inc.$744K0.39%Not reported+100.6%Q1 2026
DASHDoorDash, Inc.$526K0.28%Not reportedNewQ2 2026
CVNACarvana Co.$426K0.23%Not reportedNewQ2 2026
FIGFigma, Inc.$269K0.14%Not reportedNot reportedQ3 2025
Q1 2026Reported May 15, 202612 positions
IOTSamsara Inc.$63.4M34.53%Not reportedNot reportedQ4 2022
AVBPArriVent BioPharma, Inc.$34.5M18.79%3.30%Not reportedQ1 2024
MAZEMaze Therapeutics, Inc.$30.9M16.85%2.08%Not reportedQ1 2025
CARTMaplebear Inc.$26.6M14.50%0.30%Not reportedQ3 2023
GTLBGitlab Inc.$19.9M10.86%Not reportedNot reportedQ4 2022
EIKNEikon Therapeutics, Inc.$3.23M1.76%0.56%NewQ1 2026
GUTSFractyl Health, Inc.$2.24M1.22%3.08%Not reportedQ2 2025
LIFEEthos Technologies Inc.$829K0.45%0.45%NewQ1 2026
CPNGCoupang, Inc.$692K0.38%Not reportedNewQ1 2026
AMZNAmazon Com Inc$538K0.29%0.00%NewQ1 2026
METAMeta Platforms, Inc.$376K0.21%Not reportedNewQ1 2026
FIGFigma, Inc.$314K0.17%Not reportedNot reportedQ3 2025
Q4 2025Reported Feb 17, 20267 positions
IOTSamsara Inc.$70.9M31.97%Not reported-78.4%Q4 2022
MAZEMaze Therapeutics, Inc.$42.9M19.35%2.10%Not reportedQ1 2025
GTLBGitlab Inc.$34.6M15.59%Not reportedNot reportedQ4 2022
CARTMaplebear Inc.$32M14.42%0.29%Not reportedQ3 2023
AVBPArriVent BioPharma, Inc.$30.1M13.56%3.52%Not reportedQ1 2024
GUTSFractyl Health, Inc.$10.7M4.85%3.18%Not reportedQ2 2025
FIGFigma, Inc.$555K0.25%Not reported-98.3%Q3 2025
Q3 2025Reported Nov 14, 20258 positions
CRCLCircle Internet Group, Inc.$2.52B82.89%Not reported-5.6%Q2 2025
IOTSamsara Inc.$345M11.34%Not reported-22.8%Q4 2022
FIGFigma, Inc.$45.5M1.50%Not reportedNewQ3 2025
GTLBGitlab Inc.$41.5M1.37%Not reportedNot reportedQ4 2022
AVBPArriVent BioPharma, Inc.$27.6M0.91%3.66%Not reportedQ1 2024
MAZEMaze Therapeutics, Inc.$26.9M0.88%2.15%Not reportedQ1 2025
CARTMaplebear Inc.$26.1M0.86%0.27%Not reportedQ3 2023
GUTSFractyl Health, Inc.$7.77M0.26%3.69%Not reportedQ2 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.